Home › Funds › Royce & Associates › CORT
Royce & Associates position in CORT
CORCEPT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)133.30K sh
Reported value held$11.59M
Portfolio Weight0.09%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 49.86K | $981.00K | New |
| Q4 2021 | 52.90K | $1.05M | Add |
| Q1 2022 | 280.38K | $6.31M | Add |
| Q2 2022 | 280.45K | $6.67M | Hold |
| Q3 2022 | 272.71K | $6.99M | Reduce |
| Q4 2022 | 259.47K | $5.27K | Reduce |
| Q1 2023 | 306.25K | $6.63K | Add |
| Q2 2023 | 293.74K | $6.54M | Reduce |
| Q3 2023 | 353.10K | $9.62M | Add |
| Q4 2023 | 336.07K | $10.92M | Reduce |
| Q1 2024 | 336.27K | $8.47M | Hold |
| Q2 2024 | 350.27K | $11.38M | Add |
| Q3 2024 | 363.27K | $16.81M | Add |
| Q4 2024 | 338.30K | $17.05M | Reduce |
| Q1 2025 | 189.31K | $21.62M | Reduce |
| Q2 2025 | 168.56K | $12.37M | Reduce |
| Q3 2025 | 168.56K | $14.01M | Hold |
| Q4 2025 | 166.56K | $5.80M | Reduce |
| Q1 2026 | 135.43K | $5.46M | Reduce |
| Q2 2026 | 133.30K | $11.59M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CORT
- BlackRock Inc 12.43M sh · $1.08B · Q2 2026
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Vanguard Group 9.49M sh · $330.42M · Q4 2025
- Fidelity Management & Research (FMR) 3.34M sh · $290.21M · Q2 2026
- AQR Capital Management 2.58M sh · $224.55M · Q2 2026
- Geode Capital Management 2.53M sh · $220.21M · Q2 2026
- UBS Group AG 1.38M sh · $119.79M · Q2 2026
- Charles Schwab Investment Management 1.16M sh · $100.65M · Q2 2026
- Morgan Stanley 1.14M sh · $98.91M · Q2 2026
- D. E. Shaw & Co 883.00K sh · $76.78M · Q2 2026
- Northern Trust Corp 753.80K sh · $65.54M · Q2 2026
- Two Sigma Investments 610.08K sh · $53.05M · Q2 2026